CRNX
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) has 10 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 7, 2026.
Insiders have net sold $366K over the trailing 6 months.
- Industry:Biotechnology
- CEO:R. Scott Struthers
- Employees:594
- HQ:San Diego, CA, US
- IPO:2018-07-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$366K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$8.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Vivaldi Coelho RogerioFirst filing | Director | Sale | 3,000 | $120K | Jul 7 | SEC ↗ |
Okey StephanieFirst filing | Director | Sale | 6,900 | $246K | Jun 18 | SEC ↗ |
Related companies
Crinetics Pharmaceuticals, Inc. is in the Healthcare sector.